Nuclear Medicine Department, Lariboisière Hospital, Paris-VII University, Paris, France.
Eur Ann Otorhinolaryngol Head Neck Dis. 2010 Mar;127(1):40-5. doi: 10.1016/j.anorl.2010.02.010. Epub 2010 Mar 25.
F-18 fluorodeoxyglucose positron emission tomography is now part of the initial stage III and IV cancer work-up and each time that metastasis or the presence of a second cancer is suspected that may contraindicate major surgery. Similarly, this exam should be undertaken when the conventional work-up is negative but there is isolated metastatic adenopathy. In therapeutic follow-up, a 3- or 4-month delay must be respected to prevent false-positive exams caused by inflammation. Although FDG-PET seems very promising in determining target volumes in radiotherapy, its implementation raises a number of problems that can only be resolved through the collaboration of all of the different specialists.
F-18 氟脱氧葡萄糖正电子发射断层扫描现在是初始 III 期和 IV 期癌症检查的一部分，每次怀疑转移或存在可能禁忌主要手术的第二种癌症时，都应进行此项检查。同样，当常规检查为阴性但存在孤立的转移性淋巴结时，也应进行此项检查。在治疗随访中，必须尊重 3 或 4 个月的延迟，以防止炎症引起的假阳性检查。虽然 FDG-PET 在确定放射治疗靶体积方面似乎很有前途，但它的实施提出了许多问题，这些问题只能通过所有不同专业人员的合作来解决。
